(Q71154540)

English

Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12 000 randomised children

scientific article published on 01 June 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8667921%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

0 references

Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12 000 randomised children (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8667921%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference

based on heuristic

inferred from title

1 reference

ORCID Public Data File 2021

author name string

Childhood ALL Collaborative Group

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8667921%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

language of work or name

0 references

publication date

1 June 1996

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8667921%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8667921%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

347

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8667921%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

9018

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8667921%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1783-1788

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8667921%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Why do we need systematic overviews of randomized trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991615-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Obtaining data from randomised controlled trials: how much do we need for reliable and informative meta-analyses?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991615-3

7 January 2021

based on heuristic

inferred from DOI database lookup

[Treatment of acute lymphoblastic leukemia in childhood and adolescence: results of the multicenter therapy study ALL-BFM 81]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991615-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991615-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Treating childhood acute lymphoblastic leukaemia (ALL): Summary of ten years' experience in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991615-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991615-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of 3 years versus 5 years of chemotherapy in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991615-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Three versus five years of maintenance therapy are equivalent in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991615-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The current status of the treatment of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991615-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991615-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991615-3

7 January 2021

based on heuristic

inferred from DOI database lookup

[Acute lymphoblastic leukemia therapy study BFM 79/81 in children and adolescents: intensified reinduction therapy for patients with different risk for relapse]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991615-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy of acute lymphocytic leukemia of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991615-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991615-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991615-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of different forms of central nervous system prophylaxis on neuropsychologic function in childhood leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991615-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment intensity and outcome for children with acute lymphocytic leukemia of standard risk. A Pediatric Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991615-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug dosage and remission duration in childhood lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991615-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991615-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative study of central nervous system irradiation and intensive chemotherapy early in remission of childhood acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991615-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Childhood acute lymphocytic leukemia. Study VIII

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991615-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of acute lymphoblastic leukaemia (ALL) in childhood, UKALL III: the effects of added cytosine arabinoside and/or asparaginase, and a comparison of continuous or discontinuous mercaptopurine in regimens for standard risk ALL

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991615-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(96)91615-3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8667921%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8667921%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71154540&oldid=1831726985"